[4]Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.研究論文本文探討如何發展具成本效益的精準癌症醫療，以促進創新並縮小健康不平等。Ringborg U, von Braun J, Celis J, Berns A, Baumann M, Albreht T, Abou-Zeid N, Bagnato V, Brandts C, Chen CJ, di Pietro M, Dosanjh M, Dubois T, Eggermont A, Eggert A, Ernberg I, Faithfull S, Förner J, Fröhling S, Heitor M, Hood L, Jiang W, Jönsson B, Kannan R, Leptin M, Li S, Lindgren P, Lowy D, Ma J, Markham A, Nagy P, Oberst S, Parker MI, Rodin D, Ryan K, Schüz J, Sullivan R, Tabernero J, Turkson P, Várhelyi O, Varmus H, Wang C, Weiderpass E, Wilking N. (2026) · DOI: 10.1002/1878-0261.70179